ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
26/01/2026
Voltar para busca
Dado oficial do USPTO
ENDO GENERICS PAR PHARMACEUTICAL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000097313223Classe
5, 10, 40, 41, 42, 44
Pedido
97313223
Registro
7052815
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
27/01/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 40, 41, 42, 44
Data de depósito
15/03/2022
Data de registro
16/05/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/05/2023
Última transação
27/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
99
Localização do titular
BALLSBRIDGE, DUBLIN 4, IE
Examinador
BAGLINI, KAREN
Unidade examinadora
M80
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a hexagon shape on an angle with intermittent solid vertical lines, with the words "ENDO GENERICS" in lower case font to the right and the words "PAR PHARMACEUTICAL" in title case font underneath.
Titulares e representantes
Titulares
PH HEALTH LIMITED
ENDO OPERATIONS LIMITED
Endo Pharmaceuticals Inc.
Representantes
Camille M. Miller COZEN O'CONNOR
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 40Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and medical preparations and ready-to-administer injectable pharmaceutical and medical preparations in connection with critical carecritical testingmaternal healthanesthesiafor the treatment of painallergic reactionshypotensionshockmalignant diseaseskidney disorderscelluliteskin caredermatological usefoldsscarsbody contouring and for rejuvenating the skinto provide and reverse muscle relaxationall to be used in patient care facilitieshospitalsacute care facilitieslong term care facilities and in doctor's offices; Pharmaceutical preparationsanalgesics and pain management preparationspreparations for the treatment of cancerspreparations for the treatment of urological diseases and disorderspreparations for the treatment of schizophrenia; pharmaceutical preparations for the treatment of asymmetries and defects in conditions of the human skin; pharmaceutical preparations for the treatment of diseases and disorders of the endocrine systemhormone replacement therapy preparations; drug substancesenzymes for medical purposes; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for skin care; medicated gels and creams for dermatological use; nutritional and dietary supplements; vitamins and mineral supplements; food supplements
Classe 10
Medical devices for use in treating pelvic disorders; Medical devices for use in treating pelvic organ prolapse; Medical devices for use in treating urinary incontinence; Medical devices for use in pain management and alleviation; Medical devicessurgical equipment in the fields of urology and men's health; Medical devicesintrauterine devices; Injection syringes; Injection device for pharmaceuticals and medicine
Classe 40
Manufacture of pharmaceutical products to order and specification of others; Providing technical information in the field of pharmaceutical manufacturing
Classe 41
Educational servicesconducting classesseminarsworkshops in the field of pharmaceutical preparations and medicinesmedical devices and techniques; Educational servicesconducting classesseminarsworkshops and training for doctorsnurses and others in the fields of critical carecritical testingmaternal healthrare diseases and conditionsanesthesiaaesthetic solutions to help patients feel better about their bodies
Classe 42
Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Medical research in the fields of chemicals and pharmaceuticals; Scientific research and testing services in the fields of chemicals and pharmaceuticals; Research and development of new products for others in the fields of chemicals and pharmaceuticals; Development of pharmaceutical products to specifications of others
Classe 44
Providing medical information and online medical information on the subjects of pharmaceutical preparations and medicinesmedical devices and techniques; Providing medical information and online medical and healthcare information to healthcare professionals and patients; Providing a website featuring medical information; Providing medication counseling informationadvice and data on the subjects of pharmaceutical preparations and medicine
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/09/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
14/08/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/05/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/05/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
16/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/02/2023
PUBO
PUBLISHED FOR OPPOSITION
28/02/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/02/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/01/2023
ALIE
ASSIGNED TO LIE
19/01/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
18/11/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
23/08/2022
GNSL
LETTER OF SUSPENSION E-MAILED
23/08/2022
CNSL
SUSPENSION LETTER WRITTEN
23/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/08/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/05/2022
GNRT
NON-FINAL ACTION E-MAILED
16/05/2022
CNRT
NON-FINAL ACTION WRITTEN
16/05/2022
DOCK
ASSIGNED TO EXAMINER
10/05/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
22/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/03/2022
NWAP
NEW APPLICATION ENTERED
18/03/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ENDO GENERICS PAR PHARMACEUTICAL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.